載入...
OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib
This study explored drug transporter expression levels and their impact on clinical response to imatinib and second-generation tyrosine kinase inhibitors (TKIs) in imatinib- resistant chronic myeloid leukemia (CML). Imatinib-resistant chronic phase CML patients treated with dasatinib (n=10) and nilo...
Na minha lista:
| 發表在: | Chonnam Med J |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Chonnam National University Medical School
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4276791/ https://ncbi.nlm.nih.gov/pubmed/25568846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2014.50.3.102 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|